EcoDrugPlus

Adenosine Deaminase

Ensembl ID : ENSOTSG00005042885
Gene Symbol: ADA
1 Cross references
210 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSOTSG00005000918
Gene Symbol: LOC112262666
2 Cross references
134 Possible Orthologues:

Adenosine Receptor A2b-Like

Ensembl ID : ENSOTSG00005043017
Gene Symbol: LOC112263055
3 Cross references
184 Possible Orthologues:

Adenosine Receptor A2b-Like

Ensembl ID : ENSOTSG00005007507
Gene Symbol: LOC112248351
3 Cross references
184 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSOTSG00005011489
Gene Symbol: ADRA1B
3 Cross references
185 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSOTSG00005007743
Gene Symbol: ADRA1B
1 Cross references
190 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSOTSG00005039695
Gene Symbol: ADRA1B
1 Cross references
190 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSOTSG00005011337
Gene Symbol: ADRA1BB
1 Cross references
185 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSOTSG00005005506
Gene Symbol: ADRA1D
1 Cross references
187 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSOTSG00005019507
Gene Symbol: ADRA1D
3 Cross references
187 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSOTSG00005021682
Gene Symbol: ADRA1D
1 Cross references
187 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSOTSG00005026401
Gene Symbol: ADRA2A
1 Cross references
171 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).